Results for &quot;&quot;Clinical Trials, Phase IV as Topic&quot;&quot;[mesh_terms]

Comparative Effectiveness of Phosphate Binders in Patients with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.

Nigar Sekercioglu, Lehana Thabane, Juan Pablo Díaz Martínez, Gihad Nesrallah, Christopher J Longo, Jason W Busse, Noori Akhtar-Danesh, Arnav Agarwal, Reem Al-Khalifah, Alfonso Iorio, Gordon H Guyatt

PloS one 2017;11(6):e0156891

Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial.

Pierre Fayoux, Mickael Dinomais, Helen Shaw, Nick Probert, Frédéric Villain, Denis Pouchain, Nathalie Texier, Stéphane Auvin

BMJ paediatrics open 2023;7(1):e001913

Nature-Derived Hit, Lead, and Drug-Like Small Molecules: Current Status and Future Aspects Against Key Target Proteins of Coronaviruses.

Md Junaid, Yeasmin Akter, Aysha Siddika, S M Abdul Nayeem, Afsana Nahrin, Syeda Samira Afrose, Md Muzahid Ahmed Ezaj, Muhammad Shaiful Alam

Mini reviews in medicinal chemistry 2022;22(3):498-549

Pitavastatin - results from phase III & IV.

John Betteridge

Atherosclerosis. Supplements 2011;11(3):8-14

Anticoagulation with rivaroxaban: covering a broad spectrum of thromboembolic disease.

Sebastian Schellong

Expert review of cardiovascular therapy 2014;11(7):817-28

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.

Dietmar Fries, Hanno Ulmer, Janett Kreutziger

The New England journal of medicine 2024;391(8):772-773

Vernakalant. Too dangerous in atrial fibrillation.

Prescrire international 2012;21(127):119-22

Systematic literature review and network meta-analysis of sodium-glucose co-transporter inhibitors vs metformin as add-on to insulin in type 1 diabetes.

Bryony E Langford, Marc Evans, Tao Haskins-Coulter, Molly O'Connor, Harriet E O Cant, Lucy A Eddowes, Christopher Edmonds, Amarjeet Tank

Diabetes, obesity & metabolism 2021;22(1):39-50

Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study.

R Lencioni, J Marrero, A Venook, S-L Ye, M Kudo

International journal of clinical practice 2011;64(8):1034-41

Achieving blood pressure control targets in hypertensive patients of rural China - a pilot randomized trial.

Xiao Huang, Lishun Liu, Yun Song, Lan Gao, Min Zhao, Huihui Bao, Xianhui Qin, Yanqing Wu, Qinghua Wu, Chonglei Bi, Aiping Yue, Chongqian Fang, Hai Ma, Yimin Cui, Genfu Tang, Ping Li, Yan Zhang, Jianping Li, Binyan Wang, Xiping Xu, Hong Wang, Gianfranco Parati, J David Spence, Xiaobin Wang, Yong Huo, Guangliang Chen, Xiaoshu Cheng

Trials 2021;21(1):515

Effect and safety of 4% albumin in the treatment of cardiac surgery patients: study protocol for the randomized, double-blind, clinical ALBICS (ALBumin In Cardiac Surgery) trial.

Hanna Vlasov, Tatu Juvonen, Seppo Hiippala, Raili Suojaranta, Markku Peltonen, Alexey Schramko, Kaapo Arvonen, Ulla-Stina Salminen, Ilona Kleine Budde, Tiina Eränen, Maxim Mazanikov, Mihkel Meinberg, Tommi Vähäsilta, Erika Wilkman, Ville Pettilä, Eero Pesonen

Trials 2020;21(1):235

Effect of alirocumab on coronary atheroma volume in Japanese patients with acute coronary syndromes and hypercholesterolemia not adequately controlled with statins: ODYSSEY J-IVUS rationale and design.

Junya Ako, Kiyoshi Hibi, Ken Kozuma, Katsumi Miyauchi, Yoshihiro Morino, Toshiro Shinke, Kenichi Tsujita, Kiyoko Uno, Yumiko Kawabata, Takafumi Hiro

Journal of cardiology 2019;71(6):583-589

Comparison of efficacy of rifaximin, probiotics and L-ornithine L-aspartate in overt hepatic encephalopathy: a randomized, phase IV, lactulose controlled clinical trial.

Amna Shahbaz, QurratulAin Jamil, Shahid Muhammad Iqbal, Muhammad Nauman Jamil, Jawad Akbar Khan, Mohammed Aufy

Trials 2025;26(1):534

PCSK9 inhibitors: a non-statin cholesterol-lowering treatment option.

Gregory S Pokrywka

Postgraduate medicine 2018;130(3):287-298